TECH BUYER Oct 2021 - IDC Perspective - Doc # EUR146000220

European Life Sciences Key IT Deals and Initiatives Update, Q3 2021


Nino Giguashvili
Table of Contents

Executive Snapshot

Figure: Executive Snapshot: European Life Sciences Key IT Deals and Initiatives Update, Q3 2021

Situation Overview

Expanding Pharma Beyond the Pill, Strengthening Patient Engagement

Digital Therapeutics

Virtual Reality for Patient Training

Connected Systems for Drug Delivery and Treatment Compliance

Advancing Early Detection and Precision Diagnostics, Expanding Medical Tech Services

Surveillance Testing for SARS-CoV-2

Digital Pathology, Intelligent Image Analytics

Remote Monitoring and Telehealth

Remote Diagnostics, Teleradiology

Accelerating R&D, Advancing Precision Medicine

Expediting Drug Design and Discovery, Collaboration at Scale

Genomic Research, Data Hubs

AI-Based Drug Design

Quantum and High-Performance Computing

Federated Learning

Supporting Trial Design and Execution, Enabling Decentralized Trials

Patient Matching, Recruitment, and Retention

Clinical Data Management and Operations

Accelerating the Use of Real-World Data

Enabling an Intelligent Life Sciences Enterprise

Orchestrated Customer Engagement

Digital Transformation Toward an Intelligent Life Sciences Enterprise

Facilitating Last-Mile Delivery in Face of the Pandemic

Autonomous Drone Delivery Systems

Smart Shopping and Shipping

Supporting Innovation Acceleration

Advice for the Technology Buyer

Learn More

Related Research



Related Links